Donata Lissner
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Multimodal Profiling of Peripheral Blood Identifies Proliferating Circulating Effector CD4+ T Cells as Predictors for Response to Integrin α4β7-Blocking Therapy in Inflammatory Bowel Disease.
Journal: Gastroenterology
Published: December 19, 2023
Analysis of Circulating Food Antigen-Specific T-Cells in Celiac Disease and Inflammatory Bowel Disease.
Journal: International journal of molecular sciences
Published: March 23, 2023
Expression and function of α4β7 integrin predict the success of vedolizumab treatment in inflammatory bowel disease.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: July 02, 2022
TNF hampers intestinal tissue repair in colitis by restricting IL-22 bioavailability.
Journal: Mucosal immunology
Published: January 31, 2022
Combination of Vedolizumab With Tacrolimus Is More Efficient Than Vedolizumab Alone in the Treatment of Experimental Colitis.
Journal: Inflammatory bowel diseases
Published: October 13, 2020
PuraStat in gastrointestinal bleeding: results of a prospective multicentre observational pilot study.
Journal: Surgical endoscopy
Published: September 23, 2020
Passive Smoking Increases the Risk for Intestinal Surgeries in Patients With Crohn's Disease.
Journal: Inflammatory bowel diseases
Published: December 13, 2019
Level of Tumor Necrosis Factor Production by Stimulated Blood Mononuclear Cells Can Be Used to Predict Response of Patients With Inflammatory Bowel Diseases to Infliximab.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: November 27, 2019
Cancer Surveillance in Inflammatory Bowel Diseases
Journal: Deutsche medizinische Wochenschrift (1946)
Published: June 05, 2019
Inflammatory bowel disease: cardinal signs and their diagnostics
Journal: Deutsche medizinische Wochenschrift (1946)
Published: July 05, 2018
Pulmonary Manifestation of Crohn's Disease Developed Under Treatment With Vedolizumab.
Journal: The American journal of gastroenterology
Published: January 10, 2018
Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
Journal: The American journal of gastroenterology
Published: May 28, 2017
Last Updated: 09/26/2026